Chemoinformaics analysis of d-Gluco-l-glycero-3-octulose
Molecular Weight | 240.208 | nRot | 7 |
Heavy Atom Molecular Weight | 224.08 | nRig | 1 |
Exact Molecular Weight | 240.085 | nRing | 0 |
Solubility: LogS | 0.295 | nHRing | 0 |
Solubility: LogP | -2.736 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
nHA | 8 | APOL | 30.4447 |
nHD | 7 | BPOL | 16.9193 |
QED | 0.234 |
Synth | 4.107 |
Natural Product Likeliness | 1.656 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.01 |
Pgp-sub | 0.677 |
HIA | 0.565 |
CACO-2 | -5.463 |
MDCK | 0.000961658 |
BBB | 0.533 |
PPB | 0.142634 |
VDSS | 0.507 |
FU | 0.675041 |
CYP1A2-inh | 0.007 |
CYP1A2-sub | 0.015 |
CYP2c19-inh | 0.005 |
CYP2c19-sub | 0.047 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.073 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.081 |
CYP3a4-inh | 0.002 |
CYP3a4-sub | 0.003 |
CL | 1.21 |
T12 | 0.803 |
hERG | 0.092 |
Ames | 0.048 |
ROA | 0.008 |
SkinSen | 0.047 |
Carcinogencity | 0.001 |
EI | 0.018 |
Respiratory | 0.02 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.84485 |